Palliative care providers face a host of legal and regulatory challenges when seeking to expand patients’ access to certain controlled substances. Providing therapeutic- and medically-guided patient experiences involves a deep understanding of compliance with evolving laws and safe utilization. Drugs that fall into the realm of federally controlled substances include cannabis, ketamine, MDMA and psychedelics […]
A newly established nonprofit organization aims to “transform” the end-of-life experience through the therapeutic use of psychedelics. The stated mission of Florida-based End of Life Psychedelic Care (EOLPC) is to educate health care providers, policymakers and the public as well as foster access to those substances for terminally ill patients. “Everyone deserves compassionate care as […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
